SKI Market

A+| A| A-|

Indian Indices

Sensex

74,383.19 400.01
( 0.54%)

Global Indices

Nasdaq

49,934.70 -958.41
(-1.88%)

Dow Jones

7,287.94 -119.71
(-1.62%)

Hang Seng

64,050.08 -129.19
(-0.20%)

Nikkei 225

10,254.58 27.25
(0.27%)

Forex

USD-INR

95.41 -0.12
(-0.12%)

EUR-INR

110.18 0.04
(0.03%)

GBP-INR

127.60 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541540

INE624Z01016

263.8007816

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SOLARA

2731.74

EPS(TTM)

Face Value()

Div & Yield %

Back

ashnisha industries ltd

Lloyds Enterprises announces CCI approval for scheme of merger

May 14,2026

Lloyds Enterprises announced that Competition Commission of India (CCI) has approved the proposed scheme of merger by absorption of Lloyds Infrastructure & Construction (transferor company 1), Metalfab Hightech (transferor company 2) and Techno Industries (transferor company 3) with Lloyds Engineering Works (transferee Company/ material subsidiary of Lloyds Enterprises).

74,383.19 400.01 ( 0.54%)

49,934.70 -958.41 (-1.88%)

7,287.94 -119.71 (-1.62%)

64,050.08 -129.19 (-0.20%)

10,254.58 27.25 (0.27%)

95.41 -0.12 (-0.12%)

110.18 0.04 (0.03%)

127.60 0.17 (0.13%)

0.60 0.00 (-0.17%)